VMSB yields 1.67% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, VMSB + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VMSB + MRK for your $10,000?
VMSB aims for high current income and long-term capital appreciation. The fund actively invests in income-producing bonds, which may include corporate and government bonds, including from emerging markets, loans, asset-backed securities, and money market instruments. The fund has broad flexibility across debt instruments and derivatives, and its average duration generally ranges from 0 to 10 years, based on an interest rate risk profile. Securities may be of any credit quality. The fund can use various trading strategies, such as delayed delivery, forward commitment (including TBA trades), buy backs, and dollar rolls. It can invest in derivatives for hedging, tactical allocation, or to enhance returns. Management of the portfolio combines top-down macroeconomic views with bottom-up analysis, considering sector allocation, security selection, duration, and yield curve positioning. The team utilizes proprietary research, quantitative models, stress testing, and ongoing risk management.
Full VMSB Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.